FDA Alerts Providers and Patients to Check for Premature Battery Depletion in Certain Medtronic Pacemakers

May 7, 2019

The U.S. Food and Drug Administration (FDA) is issuing this safety communication to alert health care providers and patients about issues that may cause batteries in certain Medtronic implantable pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) to drain more quickly than expected without warning patients or health care providers.

Audience:

  • Patients with a Medtronic pacemaker or cardiac resynchronization therapy pacemaker (CRT-P)
  • Caregivers of patients with a Medtronic pacemaker or CRT-P
  • Cardiologists, electrophysiologists, cardiac surgeons, and primary care physicians treating patients with heart failure or heart rhythm problems using a Medtronic pacemaker or CRT-P

View the FDA Alert